What is Scotiabank's Forecast for Methanex FY2026 Earnings?

Key Points

• Scotiabank cut its FY2026 EPS forecast for Methanex to $8.86 from $9.34 while maintaining an Outperform rating and an $80 price target; the consensus current full-year EPS estimate is $5.96.
• Methanex missed Q1 expectations, reporting $0.30 EPS versus $0.38 expected and revenue of $957.4M versus $964.8M expected, and posted a negative net margin of -1.25% despite revenue rising 8.7% year‑over‑year.
• Other analysts have mixed updates—several raised price targets (BMO, Raymond James, UBS) and MarketBeat shows a Moderate Buy consensus with a $64.90 target; the stock trades in the mid‑$60s with a market cap of ~$5.08B and a ~1.1% dividend yield.

Methanex Corporation (NASDAQ:MEOH - Free Report) TSE: MX - Analysts at Scotiabank decreased their FY2026 earnings per share (EPS) estimates for shares of Methanex in a research report issued on Friday, May 1st. Scotiabank analyst B. Isaacson now forecasts that the specialty chemicals company will post earnings of $8.86 per share for the year, down from their previous estimate of $9.34. Scotiabank has a "Outperform" rating and a $80.00 price objective on the stock. The consensus estimate for Methanex's current full-year earnings is $5.96 per share.

Several other equities analysts have also recently issued reports on the company. BMO Capital Markets boosted their price objective on Methanex from $65.00 to $70.00 and gave the company an "outperform" rating in a report on Wednesday, March 18th. Raymond James Financial boosted their price objective on Methanex from $52.00 to $65.00 and gave the company a "market perform" rating in a report on Thursday, April 16th. Zacks Research raised Methanex from a "strong sell" rating to a "hold" rating in a report on Tuesday, April 14th. Weiss Ratings cut Methanex from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday. Finally, UBS Group boosted their price objective on Methanex from $70.00 to $75.00 and gave the company a "buy" rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $64.90.

Methanex Stock Performance

Shares of MEOH stock opened at $65.72 on Wednesday. The stock has a market cap of $5.08 billion, a PE ratio of -134.12 and a beta of 0.60. The business has a 50-day simple moving average of $56.80 and a 200-day simple moving average of $46.64. The company has a quick ratio of 1.26, a current ratio of 1.96 and a debt-to-equity ratio of 0.98. Methanex has a 52-week low of $31.57 and a 52-week high of $66.75.

Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX last posted its quarterly earnings results on Wednesday, April 29th. The specialty chemicals company reported $0.30 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.08). The firm had revenue of $957.42 million for the quarter, compared to analysts' expectations of $964.76 million. Methanex had a negative net margin of 1.25% and a positive return on equity of 2.96%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.30 EPS.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of MEOH. Amundi lifted its stake in Methanex by 3.9% in the 1st quarter. Amundi now owns 22,791 shares of the specialty chemicals company's stock worth $800,000 after purchasing an additional 848 shares in the last quarter. Hsbc Holdings PLC purchased a new position in Methanex in the 2nd quarter worth approximately $419,000. Invesco Ltd. lifted its stake in Methanex by 15.7% in the 2nd quarter. Invesco Ltd. now owns 249,231 shares of the specialty chemicals company's stock worth $8,250,000 after purchasing an additional 33,827 shares in the last quarter. AXA S.A. purchased a new position in Methanex in the 2nd quarter worth approximately $166,000. Finally, Qube Research & Technologies Ltd lifted its stake in Methanex by 327.0% in the 2nd quarter. Qube Research & Technologies Ltd now owns 47,284 shares of the specialty chemicals company's stock worth $1,565,000 after purchasing an additional 36,211 shares in the last quarter. 73.49% of the stock is owned by hedge funds and other institutional investors.

Methanex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.185 dividend. This represents a $0.74 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 16th. Methanex's dividend payout ratio (DPR) is -151.02%.

About Methanex

Methanex Corporation is a Vancouver, Canada–based company and one of the world's largest producers and suppliers of methanol. The company manufactures methanol, a key feedstock for a wide range of chemical products and industrial applications. Methanex markets its product to customers in energy, plastics, paints and coatings, and various chemical sectors, positioning the company as a critical link in the global supply chain for basic chemicals.

The company's core product, methanol, serves as a building block for downstream chemicals such as formaldehyde, acetic acid and methyl tertiary butyl ether (MTBE).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.